Mode of Death in Octogenarians Treated With Cardiac Resynchronization Therapy

Journal of Cardiac Failure

Volumn 22, Issue 12, 2016, Pages 970-977

  Martens, Pieter ^a,b   Verbrugge, Frederik H ^a   Nijst, Petra ^a,b   Dupont, Matthias ^a   Mullens, Wilfried ^a,b  

^a DEPARTMENT OF CARDIOLOGY   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

Author keywords

CRT; Elderly; heart failure readmission; reverse remodeling

Indexed keywords

AGED; AGING; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; CONTROLLED STUDY; DEATH; DISEASE EXACERBATION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART VENTRICLE REMODELING; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; PRIORITY JOURNAL; TACHYCARDIA; VERY ELDERLY; AGE; HEART STROKE VOLUME; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 84999018256     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2016.09.023     Document Type: Article

References (32)

1. 1 McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Bohm, M., Dickstein, K., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33 (2012), 1787–1847.
2. 2 Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E. Jr, Drazner, M.H., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 128 (2013), e240–327.
3. 3 Abraham, W.T., Young, J.B., Leon, A.R., Adler, S., Bank, A.J., Hall, S.A., et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 110 (2004), 2864–2868.
4. 4 Bristow, M.R., Saxon, L.A., Boehmer, J., Krueger, S., Kass, D.A., De Marco, T., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004), 2140–2150.
5. 5 Cleland, J.G., Daubert, J.C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005), 1539–1549.
6. 6 Higgins, S.L., Hummel, J.D., Niazi, I.K., Giudici, M.C., Worley, S.J., Saxon, L.A., et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 42 (2003), 1454–1459.
7. 7 Young, J.B., Abraham, W.T., Smith, A.L., Leon, A.R., Lieberman, R., Wilkoff, B., et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA 289 (2003), 2685–2694.
8. 8 Dickstein, K., Bogale, N., Priori, S., Auricchio, A., Cleland, J.G., Gitt, A., et al. The European cardiac resynchronization therapy survey. Eur Heart J 30 (2009), 2450–2460.
9. 9 Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 129 (2014), e28–292.
10. 10 Bleeker, G.B., Schalij, M.J., Molhoek, S.G., Boersma, E., Steendijk, P., Bax, J.J., et al. Comparison of effectiveness of cardiac resynchronization therapy in patients <70 versus ≥70 years of age. Am J Cardiol 96 (2005), 420–422.
11. 11 Verbrugge, F.H., Dupont, M., DeVusser, P., Rivero-Ayerza, M., VanHerendael, H., Vercammen, J., et al. Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians. Eur J Heart Fail 15 (2013), 203–210.
12. 12 Kron, J., Aranda, J.M. Jr, Miles, W.M., Burkart, T.A., Woo, G.W., Saxonhouse, S.J., et al. Benefit of cardiac resynchronization in elderly patients: results from the Multicenter Insync Randomized Clinical Evaluation (MIRACLE) and Multicenter Insync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. J Interv Card Electrophysiol 25 (2009), 91–96.
13. 13 Heidenreich, P.A., Tsai, V., Bao, H., Curtis, J., Goldstein, M., Curtis, L., et al. Does age influence cardiac resynchronization therapy use and outcome?. JACC Heart Fail 3 (2015), 497–504.
14. 14 Suleiman, M., Goldenberg, I., Haim, M., Schliamser, J.E., Boulos, M., Ilan, M., et al. Clinical characteristics and outcomes of elderly patients treated with an implantable cardioverter-defibrillator or cardiac resynchronization therapy in a real-world setting: data from the Israeli ICD Registry. Heart Rhythm 11 (2014), 435–441.
15. 15 Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J.J., Ponikowski, P., Poole-Wilson, P.A., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10 (2008), 933–989.
16. 16 Brignole, M., Auricchio, A., Baron-Esquivias, G., Bordachar, P., Boriani, G., Breithardt, O.A., et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Rev Esp Cardiol (Engl Ed), 67, 2014, 58.
17. 17 Daubert, J.C., Saxon, L., Adamson, P.B., Auricchio, A., Berger, R.D., Beshai, J.F., et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace 14 (2012), 1236–1286.
18. 18 Mullens, W., Grimm, R.A., Verga, T., Dresing, T., Starling, R.C., Wilkoff, B.L., et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol 53 (2009), 765–773.
19. 19 Mullens, W., Kepa, J., DeVusser, P., Vercammen, J., Rivero-Ayerza, M., Wagner, P., et al. Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy. Am J Cardiol 108 (2011), 409–415.
20. 20 Verbrugge, F.H., Verhaert, D., Grieten, L., Dupont, M., Rivero-Ayerza, M., De Vusser, P., et al. Revisiting diastolic filling time as mechanistic insight for response to cardiac resynchronization therapy. Europace 15 (2013), 1747–1756.
21. 21 http://statbel.fgov.be/nl/modules/publications/statistiques/bevolking/downloads/bevolking_sterftetafels.jsp Available at:; Accessed May 9, 2016.
22. 22 von Elm, E., Altman, D.G., Egger, M., Pocock, S.J., Gotzsche, P.C., Vandenbroucke, J.P., The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370 (2007), 1453–1457.
23. 23 Schiller, N.B., Shah, P.M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., et al., American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989), 358–367.
24. 24 Hinkle, L.E. Jr, Thaler, H.T., Clinical classification of cardiac deaths. Circulation 65 (1982), 457–464.
25. 25 Martens, P., Nijst, P., Mullens, W., Current approach to decongestive therapy in acute heart failure. Curr Heart Fail Rep 12 (2015), 367–378.
26. 26 Linde, C., Abraham, W.T., Gold, M.R., St John, S.M., Ghio, S., Daubert, C., Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 52 (2008), 1834–1843.
27. 27 Ponikowski, P., Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G., Coats, A.J., et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 18 (2016), 891–975.
28. 28 Dodson, J.A., Fried, T.R., Van Ness, P.H., Goldstein, N.E., Lampert, R., Patient preferences for deactivation of implantable cardioverter-defibrillators. JAMA Intern Med 173 (2013), 377–379.
29. 29 Healey, J.S., Hallstrom, A.P., Kuck, K.H., Nair, G., Schron, E.P., Roberts, R.S., et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J 28 (2007), 1746–1749.
30. 30 Mezu, U., Adelstein, E., Jain, S., Saba, S., Effectiveness of implantable defibrillators in octogenarians and nonagenarians for primary prevention of sudden cardiac death. Am J Cardiol 108 (2011), 718–722.
31. 31 Steinberg, B.A., Al-Khatib, S.M., Edwards, R., Han, J., Bardy, G.H., Bigger, J.T., et al. Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. JACC Heart Fail 2 (2014), 623–629.
32. 32 Marijon, E., Leclercq, C., Narayanan, K., Boveda, S., Klug, D., Lacaze-Gadonneix, J., et al. Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CERTITUDE cohort study. Eur Heart J 36 (2015), 2767–2776.